Innovative microscale workflow from fungi cultures to Cell Wall-Degrading Enzyme screening

This study aimed at developing a complete miniaturized high-throughput screening workflow for the evaluation of the Cell Wall-Degrading Enzyme (CWDE) activities produced by any fungal strain directly cultivated on raw feedstock in a submerged manner. In this study, wheat straw was selected as model substrate as it represents an important carbon source but yet poorly valorised to yield high added value products. Fungi were grown in a microbioreactor in a high-throughput (HT) way to replace the fastidious shaking flask cultivations. Both approaches were compared in order to validate our new methodology. The range of CWDE activities produced from the cultures was assayed using AZO-died and pNP-linked substrates in an SBS plate format using a Biomek FXp pipetting platform. As highlighted in this study, it was shown that the CWDE activities gathered from the microbioreactor cultivations were similar or higher to those obtained from shake flasks cultures, with a lower standard deviation on the measured values, making this new method much faster than the traditional one and suitable for HT CWDE production thanks to its pipetting platform compatibility. Also, the results showed that the enzymatic activities measured were the same when doing the assay manually or using the automated method.     

Cost of In-Patient Care over 7 Years among Surgically and Conventionally Treated Obese Patients

Objective: Bariatric surgery improves cardiovascular risk factors and quality of life, but few studies have directly addressed the relation between obesity treatment and hospitalization costs. This prospective controlled study compares in-patient care between surgically and conventionally treated obese patients. Research Methods and Procedures: A total of 962 surgically and conventionally treated obese patients from the intervention study, Swedish Obese Subjects, were followed for 6 years. Changes in days of hospitalization and hospitalization costs were analyzed. Information on hospitalizations for each subject were obtained from the Swedish Hospital Discharge Register. Results: After 6 years, weight change was −16.7% in the surgical group and +0.9% in the control group (p < 0.0001). The cumulated hospital stay over 6 years was 23.4 days in the surgical group and 6.9 days in the control group (p < 0.0001). The average hospital cost for the surgical intervention was US$4300. Incremental costs that could be attributable to obesity surgery averaged US$1200 per year. After exclusion of hospitalizations for the surgical intervention and conditions common after bariatric surgery, there were no significant differences between the groups in number of hospital days or hospitalization costs. Discussion: Our experience from bariatric surgery indicates that average weight reductions of 16% will not reduce hospitalization costs over 6 years. Costs of bariatric surgery are limited and seem to be motivated given the marked improvements of cardiovascular risk factors, cardiac structure, and function and health-related quality of life.     

High-throughput strategies for the discovery and engineering of enzymes for biocatalysis

Bioprocess and Biosystems Engineering - Innovations in novel enzyme discoveries impact upon a wide range of industries for which biocatalysis and biotransformations represent a great challenge,...     

A new device for the freeze-clamping of tissue samples

Measurement of metabolite concentrations in tissue samples involves the following procedures: Removal of the sample from the animal, temporary arrest of metabolism, extraction (including weighing, homogenization, final fixation, and neutralization) and assay. Rapid temporary fixation following the sampling of tissue is essential to prevent autolytic changes in metabolite concentrations (1,2). The freeze-clamping technique described by Wollenberger et al. (3) meets this requirement as long as the final thickness of the freeze-clamped sample is sufficiently small. For brain tissue the limit seems to be about 2 mm (4).In our laboratory we have made extensive use of the freeze-clamping tongs of Wollenberger et al., especially for small tissue samples freeze-clamped in situ. However, when in situ clamping can not be used when more than 2–3 g of tissue must be sampled, the freeze-clamping press described below has proven very useful.